Respirology

Pediatric asthma is a prevalent chronic respiratory condition, affecting more than 850,000 children in Canada under the age of 14.

A new study from Korea may pose more questions than it answers.

The injectable monoclonal antibody prevents respiratory syncytial virus in newborns and infants during their first RSV season and at-risk children during their second RSV season.

Sleep apnea is one of the most underdiagnosed sleep disorders.

The new shot called Nirsevimab—also known by the brand name Beyfortus—gives babies antibodies that provide passive immunity to RSV.

Frequent or prolonged OCS use can pose substantial health risks, but there are other options for severe asthma.

Since symptoms such as fatigue and dyspnea are common to many heart and lung diseases, pulmonary hypertension often flies under the radar of respirologists and other health professionals.

Are you up to date with the latest recommendations on treating chronic obstructive pulmonary disease? Find out here!